DE69132545D1 - Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung - Google Patents
Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner HerstellungInfo
- Publication number
- DE69132545D1 DE69132545D1 DE69132545T DE69132545T DE69132545D1 DE 69132545 D1 DE69132545 D1 DE 69132545D1 DE 69132545 T DE69132545 T DE 69132545T DE 69132545 T DE69132545 T DE 69132545T DE 69132545 D1 DE69132545 D1 DE 69132545D1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- production
- expression vector
- host cells
- recombinant dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9014961A FR2669930A1 (fr) | 1990-11-29 | 1990-11-29 | Proteine presentant une activite de type cytokine, adn recombinant, vecteur d'expression et hotes permettant son obtention. |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69132545D1 true DE69132545D1 (de) | 2001-04-05 |
Family
ID=9402736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69132545T Expired - Lifetime DE69132545D1 (de) | 1990-11-29 | 1991-11-29 | Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung |
Country Status (7)
Country | Link |
---|---|
US (1) | US6001649A (de) |
EP (1) | EP0488900B1 (de) |
JP (1) | JPH05503945A (de) |
AT (1) | ATE199377T1 (de) |
DE (1) | DE69132545D1 (de) |
FR (1) | FR2669930A1 (de) |
WO (1) | WO1992009629A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995031467A1 (en) * | 1994-05-16 | 1995-11-23 | Human Genome Sciences, Inc. | Monocyte chemotactic protein-4 |
ES2165390T3 (es) * | 1994-05-16 | 2002-03-16 | Human Genome Sciences Inc | Proteina quimiotactica. |
US6075124A (en) * | 1994-05-16 | 2000-06-13 | Human Genome Sciences, Inc. | Human chemotactin protein |
US6100389A (en) * | 1995-04-21 | 2000-08-08 | Human Genome Sciences, Inc. | Polynucleotides encoding a human chemotactic protein |
US6391589B1 (en) | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
US6139832A (en) * | 1995-02-08 | 2000-10-31 | Human Genome Sciences, Inc. | Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides |
US7005509B1 (en) * | 1995-02-17 | 2006-02-28 | Incyte Corporation | Chemokine PANEC-1 polynucleotides and compositions and methods related thereto |
US6713605B1 (en) * | 1996-04-10 | 2004-03-30 | Kansas State University Research Foundation | Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |
US7265201B1 (en) * | 1995-06-23 | 2007-09-04 | Millennium Pharmaceuticals, Inc. | Human chemotactic cytokine |
US6410268B1 (en) | 1996-03-18 | 2002-06-25 | Human Genome Sciences, Inc. | Polynucleotides encoding chemokine alpha-3 |
NZ332318A (en) | 1996-03-19 | 2000-10-27 | Human Genome Sciences Inc | Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses |
AU3728997A (en) * | 1996-07-15 | 1998-02-09 | Incyte Pharmaceuticals, Inc. | Human monocyte chemotactic proprotein |
US6274342B1 (en) | 1996-09-18 | 2001-08-14 | Center For Blood Research, Inc. | Nucleic acid molecules encoding monocyte chemotactic protein 5 (MCP-5) molecules and uses therefor |
US6028169A (en) * | 1997-03-31 | 2000-02-22 | Human Genome Sciences, Inc. | Chemokine β-6 antagonists |
AU2903999A (en) * | 1998-03-12 | 1999-09-27 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines |
US7157418B1 (en) | 1998-07-22 | 2007-01-02 | Osprey Pharmaceuticals, Ltd. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
EP1176200A3 (de) | 2000-06-20 | 2005-01-12 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen |
US7754676B2 (en) * | 2000-09-15 | 2010-07-13 | The United States Of America As Represented By The Department Of Health And Human Services | Defensin-antigen fusion proteins |
US7897152B2 (en) * | 2000-09-18 | 2011-03-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Viral chemokine-antigen fusion proteins |
US7375192B2 (en) * | 2002-05-01 | 2008-05-20 | Human Genome Sciences, Inc. | Antibodies that specifically bind to chemokine beta-4 |
WO2012068540A2 (en) | 2010-11-19 | 2012-05-24 | Toshio Imai | Neutralizing anti-ccl20 antibodies |
FR3031100A1 (fr) | 2014-12-31 | 2016-07-01 | Equipement De Chantiers Et Locations | Dispositif de chantier perfectionne pour le recyclage d’une eau de lavage |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5155297A (en) * | 1974-10-28 | 1976-05-14 | Toppan Moore Kk | Mihirakya bunryoinakirokubutsuno sakuseihoho |
JPS6274652A (ja) * | 1985-09-30 | 1987-04-06 | Tokyo Kikai Seisakusho:Kk | 発送仕分処理システム |
IL92938A (en) * | 1989-01-01 | 1998-08-16 | Us Commerce | A polypeptide that has a mutagenic activity on monocytes and AND that encodes it |
IL92937A0 (en) * | 1989-01-31 | 1990-09-17 | Us Health | Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it |
-
1990
- 1990-11-29 FR FR9014961A patent/FR2669930A1/fr active Granted
- 1990-11-29 US US07/927,391 patent/US6001649A/en not_active Expired - Fee Related
-
1991
- 1991-11-29 EP EP91403243A patent/EP0488900B1/de not_active Expired - Lifetime
- 1991-11-29 AT AT91403243T patent/ATE199377T1/de active
- 1991-11-29 WO PCT/FR1991/000949 patent/WO1992009629A1/fr unknown
- 1991-11-29 DE DE69132545T patent/DE69132545D1/de not_active Expired - Lifetime
- 1991-11-29 JP JP4501436A patent/JPH05503945A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1992009629A1 (fr) | 1992-06-11 |
FR2669930A1 (fr) | 1992-06-05 |
FR2669930B1 (de) | 1995-04-14 |
ATE199377T1 (de) | 2001-03-15 |
EP0488900B1 (de) | 2001-02-28 |
EP0488900A1 (de) | 1992-06-03 |
JPH05503945A (ja) | 1993-06-24 |
US6001649A (en) | 1999-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69132545D1 (de) | Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung | |
BR9301944A (pt) | Derivado de proteina c,molecula de dna recombinante,celula hospedeira e formulacao farmaceutica | |
DE60040274D1 (de) | Verabreichung von nukleinsäuren und proteinen an zellen | |
CY1107099T1 (el) | Παραλλαγες αντισωματων και θραυσματα αυτων | |
FI943389A0 (fi) | Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö | |
AU1094892A (en) | Improved activation of recombinant proteins | |
DE3484377D1 (de) | Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien. | |
DE69131426D1 (de) | Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone | |
ES2124247T3 (es) | Conjugado de calcitonina y de polietilenglicol. | |
DE69033756T2 (de) | Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen | |
DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
CA2139518A1 (en) | Antigenic regions of tlp complexes and antibodies against the same | |
DE69533905D1 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung | |
DE60026666D1 (de) | Induktion von antigen-spezifischen T-Zellen durch Interferon | |
ATE143974T1 (de) | Peptide des hiv-gag proteins, ihre herstellung und verwendung | |
ATE193324T1 (de) | Rekombinante herstellung von laktoperoxidase | |
ATE62268T1 (de) | Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien. | |
MX9708877A (es) | P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa. | |
TH16884A (th) | กลุ่มหมู่ธาตุแบบโมเลกุลอนุภาคไฟฟ้าของโปลี่เอสเตอร์ที่อาจเสื่อมทางด้าสิ่งมีชีวิตและโพลี่เปปติกที่ว่องไวทางด้านสิ่งมีชีวิต |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |